Timothy Padot

Array ( [id] => 6261747 [patent_doc_number] => 20020187925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof' [patent_app_type] => new [patent_app_number] => 09/758198 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18104 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187925.pdf [firstpage_image] =>[orig_patent_app_number] => 09758198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1099081 [patent_doc_number] => 06818419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-16 [patent_title] => 'IRAK-4: compositions and methods of use' [patent_app_type] => B2 [patent_app_number] => 09/759595 [patent_app_country] => US [patent_app_date] => 2001-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25964 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818419.pdf [firstpage_image] =>[orig_patent_app_number] => 09759595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999465 [patent_doc_number] => 06911314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-28 [patent_title] => 'Screening for drugs that affect TNF receptor releasing enzyme' [patent_app_type] => utility [patent_app_number] => 09/752639 [patent_app_country] => US [patent_app_date] => 2000-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15785 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911314.pdf [firstpage_image] =>[orig_patent_app_number] => 09752639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014984 [patent_doc_number] => 20020102253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Component of bromelain' [patent_app_type] => new [patent_app_number] => 09/750210 [patent_app_country] => US [patent_app_date] => 2000-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9294 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102253.pdf [firstpage_image] =>[orig_patent_app_number] => 09750210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6834626 [patent_doc_number] => 20030162172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => '2871 receptor, a novel G-protein coupled receptor' [patent_app_type] => new [patent_app_number] => 09/741783 [patent_app_country] => US [patent_app_date] => 2000-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 25455 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162172.pdf [firstpage_image] =>[orig_patent_app_number] => 09741783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6242174 [patent_doc_number] => 20020045209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Novel potassium channel molecules and uses therefor' [patent_app_type] => new [patent_app_number] => 09/735171 [patent_app_country] => US [patent_app_date] => 2000-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 36646 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 288 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045209.pdf [firstpage_image] =>[orig_patent_app_number] => 09735171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6472952 [patent_doc_number] => 20020151477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Nuclear receptor coactivator' [patent_app_type] => new [patent_app_number] => 09/735367 [patent_app_country] => US [patent_app_date] => 2000-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 12164 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151477.pdf [firstpage_image] =>[orig_patent_app_number] => 09735367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999813 [patent_doc_number] => 20020028483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Novel potassium channel molecules and uses therefor' [patent_app_type] => new [patent_app_number] => 09/735169 [patent_app_country] => US [patent_app_date] => 2000-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 36620 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028483.pdf [firstpage_image] =>[orig_patent_app_number] => 09735169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6880173 [patent_doc_number] => 20010031460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Use of alpha 1AR subtype-selective drugs in patients with acute myocardial infarction' [patent_app_type] => new [patent_app_number] => 09/731062 [patent_app_country] => US [patent_app_date] => 2000-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4632 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031460.pdf [firstpage_image] =>[orig_patent_app_number] => 09731062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 979080 [patent_doc_number] => 06930084 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-16 [patent_title] => 'Treating arthritis with TNF receptor releasing enzyme' [patent_app_type] => utility [patent_app_number] => 09/712813 [patent_app_country] => US [patent_app_date] => 2000-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15734 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/930/06930084.pdf [firstpage_image] =>[orig_patent_app_number] => 09712813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1173261 [patent_doc_number] => 06750200 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'M2GlyR derived channel forming peptides' [patent_app_type] => B1 [patent_app_number] => 09/710419 [patent_app_country] => US [patent_app_date] => 2000-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 16309 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750200.pdf [firstpage_image] =>[orig_patent_app_number] => 09710419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231069 [patent_doc_number] => 06692936 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Nucleic acid encoding a C5A anaphylatoxin receptor' [patent_app_type] => B1 [patent_app_number] => 09/693242 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 28899 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692936.pdf [firstpage_image] =>[orig_patent_app_number] => 09693242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1080388 [patent_doc_number] => 06835546 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-28 [patent_title] => 'Drosophila G protein coupled receptors, nucleic acids, and methods related to the same' [patent_app_type] => B1 [patent_app_number] => 09/693746 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48573 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835546.pdf [firstpage_image] =>[orig_patent_app_number] => 09693746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 761069 [patent_doc_number] => 07012060 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-14 [patent_title] => 'TNF receptor and steroid hormone in a combined therapy' [patent_app_type] => utility [patent_app_number] => 09/687122 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4657 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/012/07012060.pdf [firstpage_image] =>[orig_patent_app_number] => 09687122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1284392 [patent_doc_number] => 06638726 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Screening methods for compounds useful in the treatment of polycystic kidney disease' [patent_app_type] => B1 [patent_app_number] => 09/689461 [patent_app_country] => US [patent_app_date] => 2000-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 57 [patent_no_of_words] => 12462 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638726.pdf [firstpage_image] =>[orig_patent_app_number] => 09689461 [rel_patent_id] =>[rel_patent_doc_number] =>)